THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $976,005 | -81.4% | 94,300 | -80.5% | 0.00% | -85.7% |
| Q1 2023 | $5,249,230 | -53.6% | 483,800 | -52.0% | 0.01% | -56.2% |
| Q4 2022 | $11,316,492 | +60.2% | 1,008,600 | +44.8% | 0.03% | +60.0% |
| Q3 2022 | $7,064,000 | +6825.5% | 696,600 | +6410.3% | 0.02% | – |
| Q1 2022 | $102,000 | -83.2% | 10,700 | -64.1% | 0.00% | -100.0% |
| Q1 2021 | $608,000 | -7.5% | 29,800 | -19.5% | 0.00% | 0.0% |
| Q4 2020 | $657,000 | -44.3% | 37,000 | -53.6% | 0.00% | -33.3% |
| Q3 2020 | $1,180,000 | +9.4% | 79,800 | +55.3% | 0.00% | 0.0% |
| Q2 2020 | $1,079,000 | +379.6% | 51,400 | +729.0% | 0.00% | +200.0% |
| Q3 2016 | $225,000 | – | 6,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |